Morgan Stanley’s Palisade Bio PALI Stock Holding History

Morgan Stanley’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.97M	Buy	4,551,533 +409,087	+10%	+$744K	﹤0.01%	3765
2025 Q4	$9.73M	Buy	4,142,446 +4,133,828	+47,967%	+$7.95M	﹤0.01%	3638
2025 Q3	$7.41K	Buy	8,618 +8,611	+123,014%	+$6.73K	﹤0.01%	6981
2025 Q2	$5	Sell	7 -621	-99%	-$445	﹤0.01%	8048
2025 Q1	$428	Buy	628 +621	+8,871%	+$734	﹤0.01%	7395
2024 Q4	$12	Sell	7 -133	-95%	-$350	﹤0.01%	7903
2024 Q3	$497	Hold	140	–	–	﹤0.01%	7299
2024 Q2	$630	Sell	140 -1	-0.7%	-$5	﹤0.01%	7205
2024 Q1	$841	Sell	141 -140	-50%	-$977	﹤0.01%	7191
2023 Q4	$2.49K	Buy	281 +145	+107%	+$1.27K	﹤0.01%	7110
2023 Q3	$1.19K	Hold	136	–	–	﹤0.01%	7214
2023 Q2	$3.47K	Sell	136 -79	-37%	-$1.97K	﹤0.01%	7066
2023 Q1	$11.4K	Buy	215 +68	+46%	+$2.39K	﹤0.01%	6838
2022 Q4	$11.5K	Buy	147 +59	+67%	+$3.42K	﹤0.01%	6885
2022 Q3	$6K	Buy	88 +79	+878%	+$16.7K	﹤0.01%	7214
2022 Q2	$3K	Hold	9	–	–	﹤0.01%	7521
2022 Q1	$7K	Hold	9	–	–	﹤0.01%	7508
2021 Q4	$9K	Buy	9 +3	+50%	+$5.24K	﹤0.01%	7506
2021 Q3	$12K	Buy	6 +1	+20%	+$2.21K	﹤0.01%	7274
2021 Q2	$16K	Buy	+5	New	+$22.7K	﹤0.01%	7074
2021 Q1	–	Hold	0	–	–	–	7216
2020 Q4	–	Hold	0	–	–	–	7090
2020 Q3	–	Hold	0	–	–	–	6805
2020 Q2	–	Hold	0	–	–	–	6689
2020 Q1	–	Hold	0	–	–	–	6662
2019 Q4	–	Hold	0	–	–	–	6728
2019 Q3	–	Hold	0	–	–	–	6717
2019 Q2	–	Hold	0	–	–	–	6709
2019 Q1	–	Hold	0	–	–	–	6526
2018 Q4	–	Hold	0	–	–	–	6685
2018 Q3	–	Hold	0	–	–	–	6638
2018 Q2	–	Hold	0	–	–	–	6510
2018 Q1	–	Hold	0	–	–	–	6393
2017 Q4	–	Hold	0	–	–	–	6236
2017 Q3	–	Hold	0	–	–	–	6259
2017 Q2	–	Hold	0	–	–	–	6113
2017 Q1	–	Hold	0	–	–	–	6184
2016 Q4	–	Hold	0	–	–	–	6305
2016 Q3	–	Hold	0	–	–	–	6235
2016 Q2	–	Hold	0	–	–	–	6262
2016 Q1	–	Hold	0	–	–	–	6050
2015 Q4	–	Hold	0	–	–	–	5966
2015 Q3	–	Hold	0	–	–	–	5868
2015 Q2	–	Hold	0	–	–	–	5402
2015 Q1	–	Hold	0	–	–	–	5673
2014 Q4	–	Hold	0	–	–	–	4954
2014 Q3	–	Hold	0	–	–	–	4587
2014 Q2	–	Hold	0	–	–	–	4263
2014 Q1	–	Hold	0	–	–	–	3732
2013 Q4	–	Hold	0	–	–	–	5022
2013 Q3	–	Hold	0	–	–	–	5177

Other funds holding PALI

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Morgan Stanley's PALI Position: Q1 2026 in Review

Morgan Stanley increased its Palisade Bio (PALI) stake by 9.9% in Q1 2026, buying an estimated $744K and bringing the position to 4,551,533 shares worth $7.97M. The position accounts for ﹤0.01% of the portfolio, ranked #3765.

Morgan Stanley first reported a position in PALI in Q2 2021 and has held it in 20 quarters since. The position peaked at $9.73M in Q4 2025. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

Morgan Stanley held 4,551,533 shares of Palisade Bio worth $7.97M as of Q1 2026.
Morgan Stanley bought 409,087 Palisade Bio shares in Q1 2026, an estimated $744K.
Palisade Bio made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #3765 holding.
Morgan Stanley first reported a position in Palisade Bio in Q2 2021 and has held it in 20 quarters since.
Morgan Stanley's Palisade Bio position peaked at $9.73M in Q4 2025.
96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.